PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng^™ with OsteoCushion^™ Technology

PetVivo Holdings, Inc. released the results of a clinical study conducted by Inotiv, Inc. which examined the safety of intra-articular injections of a collagen-elastin hydrogel microparticulate biomaterial into the joints of dogs.